INSPIRE PHARMACEUTICALS INC - FORM 10-K - EX-23.1 - CONSENT OF PRICEWATERHOUSECOOPERS LLC - February 25, 2011

Attached files

file filename
10-K - FORM 10-K - INSPIRE PHARMACEUTICALS INCd10k.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A) - INSPIRE PHARMACEUTICALS INCdex311.htm
EX-10.57 - AMENDED AND RESTATED DIRECTOR COMPENSATION POLICY, DATED NOVEMBER 17, 2010 - INSPIRE PHARMACEUTICALS INCdex1057.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 - INSPIRE PHARMACEUTICALS INCdex321.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 - INSPIRE PHARMACEUTICALS INCdex322.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A) - INSPIRE PHARMACEUTICALS INCdex312.htm

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-169791 and 333-147733) and Form S-8 (Nos. 333-56360, 333-130496, 333-148185, 333-165555, 333-166955, 333-169366 and 333-169369) of Inspire Pharmaceuticals, Inc. of our report dated February 24, 2011 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

 

/s/ PricewaterhouseCoopers LLP

Raleigh, North Carolina

February 24, 2011

INSPIRE PHARMACEUTICALS INC Reports